Covea Finance Biomarin Pharmaceutical Inc Transaction History
Covea Finance
- $2.68 Billion
- Q2 2025
A detailed history of Covea Finance transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Covea Finance holds 135,300 shares of BMRN stock, worth $8.09 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
135,300
Previous 106,300
27.28%
Holding current value
$8.09 Million
Previous $7.51 Million
1.02%
% of portfolio
0.28%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
664Shares Held
185MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.14 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.06 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$894 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$645 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...